Abstract:Prolidase is the only human enzyme responsible for the digestion of iminodipeptides containing proline or hydroxyproline at their C-terminal end, being a key player in extracellular matrix remodeling. Prolidase deficiency (PD) is an intractable loss of function disease, characterized by mutations in the prolidase gene. The exact causes of activity impairment in mutant prolidase are still unknown. We generated three recombinant prolidase forms, hRecProl-231delY, hRecProl-E412K and hRecProl-G448R, reproducing th… Show more
“…As a consequence of this, the nucleophilic attack would be facilitated. The proposed mechanism is also supported by kinetic analysis of the Glu412Lys mutant .…”
The refined structure coordinates as well as the corresponding structure factor amplitudes have been deposited in the PDB under the accession numbers 5M4G, 5M4J, 5M4L, and 5M4Q.
“…As a consequence of this, the nucleophilic attack would be facilitated. The proposed mechanism is also supported by kinetic analysis of the Glu412Lys mutant .…”
The refined structure coordinates as well as the corresponding structure factor amplitudes have been deposited in the PDB under the accession numbers 5M4G, 5M4J, 5M4L, and 5M4Q.
“…This change is accompanied by an increased active site flexibility and leads to a complete loss of enzyme activity. It is interesting to note for this variant, that in earlier modeling studies , this effect was not predicted. It is also surprising that biochemical studies on this variant mutant suggested the presence of both ions and hinted at slightly increased affinity .…”
Section: Discussionmentioning
confidence: 71%
“…It is interesting to note for this variant, that in earlier modeling studies , this effect was not predicted. It is also surprising that biochemical studies on this variant mutant suggested the presence of both ions and hinted at slightly increased affinity . This is clearly in contradiction to the results presented here.…”
Section: Discussionmentioning
confidence: 71%
“…For some time, researchers have tried to explain the influence of particular mutations on the protein structure and function and their relation to disease. Due to the lack of experimental evidence for the structural differences induced by single amino acid alterations, molecular modeling was employed as the method of choice to investigate this problem . Here, we present for the first time direct evidence for the structural changes induced by the relevant point mutations.…”
All refined structure coordinates as well as the corresponding structure factor amplitudes have been deposited in the PDB under the accession numbers 5MBY, 5MBZ, 5MC0, 5MC1, 5MC2, 5MC3, 5MC4, 5MC5, 6H2P, 6H2Q.
“…Prolidase (PLD, EC 3.4.13.9) is a member of the matrix metalloproteinase family (5,6) . It is the only human enzyme responsible for the digestion of iminodipeptides containing proline or hydroxyproline at their C-terminal end, being a key player in collagen turnover, extracellular matrix remodeling and cell growth (5,(7)(8)(9) . Uzar et al (2012) stated that there is increased plasma prolidase enzyme activity in neuropathy due to diabetes (DN) as evidence of increased collagen turnover (10) .…”
Prolidase is a member of the matrix metalloproteinase family responsible for collagen turnover which is implicated in the pathogenesis of diabetic neuropathy (DN). 50 (F-16, M-34) subjects suffering from T2DM, 46 subjects (F-21, M-25) with Myara et al. (1984) p<0.001) and prolidase (t=5.968, p<0.001) were significantly higher in group 2 than in group 1. These findings imply a strong association between insulin resistance and increased collagen turnover in T2DM. ANOVA was performed and a strong statistical association was found in case of p<0.001)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.